# FARMAK PRAT · 66-41 · UKRAINE — FDA import alert red lists: firms subject to detention without physical examination

For FARMAK PRAT · 66-41 · UKRAINE, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is UKRAINE; product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 61 M - - 31 Phenobarbital (Anti-Convulsant); date published is 09/30/2009; address is Bud 63 Vul. Kyrylivska , Kyiv, Kyiv UKRAINE, verified against its source on 2026-09-16.

- **Firm:** FARMAK PRAT _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** UKRAINE _(verified: appears in the quote below)_
- **Address:** Bud 63 Vul. Kyrylivska , Kyiv, Kyiv UKRAINE _(verified: appears in the quote below)_
- **Date published:** 09/30/2009 _(verified: appears in the quote below)_
- **Product code:** 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 61 M - - 31 Phenobarbital (Anti-Convulsant) _(verified: each item appears in the quote below)_
- **FDA notes:** 8/24/2007. Corvalol. Korvalol. Covalolum. Detentions of this product should use the 502(f)(1) misbranding charge. FDA has determined that the Corvalol product contains undeclared phenobarbital. The agency is aware that the product is being sold Over the Counter (OTC) in Eastern European American communities for the treatment of angina; chest pains and as a sedative. This product is not approved for OTC use in the US FDA previously issued a health hazzard alert for Corvalol on July 28 1997. | 8/24/2007. Corvalol. Korvalol. Covalolum. Detentions of this product should use the 502(f)(1) misbranding charge. FDA has determined that the Corvalol product contains undeclared phenobarbital. The agency is aware that the product is being sold Over the Counter (OTC) in Eastern European American communities for the treatment of angina; chest pains and as a sedative. This product is not approved for OTC use in the US FDA previously issued a health hazzard alert for Corvalol on July 28 1997. _(verified: each item appears in the quote below)_

## What the source says

> FARMAK PRAT Date Published : 09/30/2009 Bud 63 Vul. Kyrylivska , Kyiv, Kyiv UKRAINE 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 09/30/2009 Notes: 8/24/2007. Corvalol. Korvalol. Covalolum. Detentions of this product should use the 502(f)(1) misbranding charge. FDA has determined that the Corvalol product contains undeclared phenobarbital. The agency is aware that the product is being sold Over the Counter (OTC) in Eastern European American communities for the treatment of angina; chest pains and as a sedative. This product is not approved for OTC use in the US FDA previously issued a health hazzard alert for Corvalol on July 28 1997. 61 M - - 31 Phenobarbital (Anti-Convulsant) Date Published: 09/30/2009 Notes: 8/24/2007. Corvalol. Korvalol. Covalolum. Detentions of this product should use the 502(f)(1) misbranding charge. FDA has determined that the Corvalol product contains undeclared phenobarbital. The agency is aware that the product is being sold Over the Counter (OTC) in Eastern European American communities for the treatment of angina; chest pains and as a sedative. This product is not approved for OTC use in the US FDA previously issued a health hazzard alert for Corvalol on July 28 1997.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).